1. Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutations
   CHENGJUN FENG et al, 2016, Oncology Reports CrossRef
2. EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma
   Timothy D. Clay et al, 2017, Medical Oncology CrossRef
3. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis
   Kun Ji et al, 2016, PLOS ONE CrossRef
4. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis
   Mengting Tong et al, 2017, PLOS ONE CrossRef
5. Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics
   Saumya Srivastava et al, 2022, Seminars in Cancer Biology CrossRef
6. CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer
   Hai-bo Shen et al, 2013, Tumor Biology CrossRef
7. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis
   Pin Wu et al, 2016, Oncotarget CrossRef
8. Antitumor effect of guava leaves on lung cancer: A network pharmacology study
   Lirong Jiang et al, 2020, Arabian Journal of Chemistry CrossRef
9. Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis
   Mu-xing Li et al, 2015, PLOS ONE CrossRef
10. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis
    Liping Qiu et al, 2022, BMC Cancer CrossRef
11. Expression and Clinical Significance of STAT3, P-STAT3, and VEGF-C in Small Cell Lung Cancer
    Xue Zhao et al, 2012, Asian Pacific Journal of Cancer Prevention CrossRef
12. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer
    Y.H. Xu et al, 2014, European Journal of Surgical Oncology (EJSO) CrossRef
13. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner
    Songping Xie et al, 2017, Oncology Reports CrossRef
14. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
    Weiqiang Zhou et al, 2019, Current Medicinal Chemistry CrossRef
15. CXCR4 over-expression and survival in cancer: A system review and meta-analysis
    Hongli Zhao et al, 2015, Oncotarget CrossRef
16. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell
    Zhidong Wang et al, 2016, Tumor Biology CrossRef
17. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer
    Claudia Stumpf et al, 2018, Journal of Cancer Research and Clinical Oncology CrossRef
18. Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome
    Kathleen C. Light et al, 2013, Psychoneuroendocrinology CrossRef
19. Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives
    Paweł Kiełb et al, 2023, Biomedicines CrossRef